$FMC

Pfeiffer Nicholas sold $16K of FMC

Pfeiffer Nicholas (Corporate Controller) sold 1,251 shares of FMC CORP (FMC) at $12.78 on 2026-09-09.

Original reporting
SEC EDGAR · Pfeiffer Nicholas
Published Sep 10, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 10, 2026, 9:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FMC
Neutral
high confidence
Mentioned
$FMC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FMCNeutralLow
01

Why it matters

The sale is a routine insider transaction with limited market relevance.

02

Market read

Minor insider sell; unlikely to affect FMC's stock price.

03

What to watch

Potential upcoming corporate actions or earnings that may prompt insider activity.

Relevance 3/10Novelty 4/10Timing: filing today

Background

SEC Form 4 filings disclose insider transactions; this is the first public report of this sale.

Company-level read

Ticker impact

$FMCNeutralHigh confidence
Context

Corporate Controller Nicholas Pfeiffer sold 1,251 shares of FMC for $15,982, reducing his stake to 28,513 shares.

Expected impact

No significant price impact expected.

Evidence & confidence

The transaction size (~$16K) is small relative to FMC's market cap and typical daily volume, and the insider retained a sizable position.

Market effects

None

None

None

Counterpoint

Even small insider sales can signal concerns; monitor for further disposals.

Key entities

  • FMC Corp

    Pharmaceutical and chemical manufacturing firm.

  • Nicholas Pfeiffer

    Corporate Controller of FMC, reporting officer.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FMCMedAI 8/10

FMC (FMC) Q2 2026 Earnings Call Transcript

FMC Corp. held its Q2 2026 earnings call. It reported Q1 revenue of $762 million, down 4% year over year, and adjusted EBITDA of $72 million. Full-year guidance calls for revenue of $3.6 billion to $3.8 billion and adjusted EBITDA of $670 million to $730 million. The company targets $1 billion debt reduction in 2026 via an India business sale and other disposals.

$FMCMed

Why FMC Corporation Rallied Today

Shares of FMC Corporation (FMC +18.18%) rallied on Thursday, up 15.8% as of 12:03 p.m. EDT. The agricultural chemicals company reported earnings last night. While the initial market reaction was negative due to a revenue miss and guidance cut, there was apparently enough good news to trigger a relief rally in this very beaten-down stock. ( 18.18 %) $ 1.82 $ 11.83 $1.3BMarket cap calculated using publicly traded shares outstanding only.

$FMCMedAI 8/10

FMC Corporation reports second quarter 2026 results with Adjusted EBITDA above high end of guidance range and solid cash generation

FMC Corporation (NYSE: FMC) reported Q2 2026 revenue of $867 million, down 17% year over year, and Adjusted EBITDA of $153 million. GAAP net loss was $187 million, or $1.49 per diluted share. Cash from operations rose to $363 million. FMC lowered full-year 2026 guidance, including revenue excluding India to $3.50-$3.70 billion and Adjusted EBITDA to $620-$680 million.

$FMCMedAI 8/10

FMC CORP (FMC): Results of Operations and Financial Condition

FMC CORP (FMC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FMC Corporation 2929 Walnut Street Philadelphia, PA 19104 USA News Release 215.299.6000 fmc.com For Release: Immediate Media contact: Nicole Canning +1.215.299.5916 Nicole.Canning@fmc.com Investor Contact: Curt Brooks + 1 . 215.299.6137 Curt.Brooks@fmc.com FMC Corpor

$CTVAMed

Corteva stock hits all-time high at 89.46 USD By Investing.com

Corteva Inc. (CTVA) shares hit an all-time high of $89.46 and are about 0.99% below its 52-week high, up 31% YTD and 21.76% over one year. InvestingPro says the stock looks overvalued versus fair value, with P/E 47.75. Morgan Stanley reiterated Overweight with a $95 target; Corteva also announced a crop protection spinoff board and a $200 million prepurchase deal with FMC.